Package 76420-865-12

{"route": ["ORAL"], "spl_id": "259ac6fd-2a83-04c0-e063-6394a90af566", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313412", "313413"], "spl_set_id": ["81385ce2-1d82-4987-8e18-83c823e10b99"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (76420-865-12)", "package_ndc": "76420-865-12", "marketing_start_date": "20241029"}, {"sample": false, "description": "150 TABLET in 1 BOTTLE (76420-865-15)", "package_ndc": "76420-865-15", "marketing_start_date": "20241029"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-865-30)", "package_ndc": "76420-865-30", "marketing_start_date": "20241029"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-865-60)", "package_ndc": "76420-865-60", "marketing_start_date": "20241029"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-865-90)", "package_ndc": "76420-865-90", "marketing_start_date": "20241029"}], "brand_name": "Tizanidine", "product_id": "76420-865_259ac6fd-2a83-04c0-e063-6394a90af566", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "76420-865", "generic_name": "Tizanidine", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA076286", "marketing_category": "ANDA", "marketing_start_date": "20210615", "listing_expiration_date": "20261231"}